Legal Marijuana Market Size, Share, Industry Analysis Report By Product Type (Buds, Oils & Concentrates, Tinctures), By Application, By Medical Application, By Compound, By Mode of Delivery, By Region – Market Forecast, 2025–2034
Description
The legal marijuana market size is expected to reach USD 1,941.95 billion by 2034, according to a new study by Polaris Market Research. The report “Legal Marijuana Market Share, Size, Trends, Industry Analysis Report By Product Type (Buds, Oils & Concentrates, Tinctures), By Application, By Medical Application, By Compound, By Mode of Delivery, By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Legal marijuana can be defined as cannabis and its derivatives that are cultivated, processed, and distributed in compliance with established laws for medical, therapeutic, and recreational purposes. The market is witnessing growth due to the rapid integration of cannabis into mainstream healthcare and wellness industries, driven by increasing scientific validation of its therapeutic benefits. This rapid growth has led to the development of standardized, high-quality products designed to meet diverse consumer needs, while boosting greater trust among both medical professionals and end-users. The demand is further boosted by ongoing innovation in product formulations and delivery methods as awareness of these benefits grows.
The rising level of institutional investments and corporate participation contributes to the expansion opportunities, as businesses recognize the important economic potential of the legal marijuana industry. Major players are leveraging advanced cultivation technologies, sophisticated branding strategies, and sustainable practices to differentiate themselves in a competitive market. This professionalization of the industry is improving product quality and availability and also contributing to its long-term legitimacy and stability, paving the way for sustained global growth.
Legal Marijuana Market Report Highlights
In terms of application, the recreational segment is projected to register a CAGR of 40.0% during the forecast period, driven by expanding adult-use legalization and evolving societal acceptance of recreational cannabis.
Based on product type, in 2024, the buds segment held a 64.1% market share, favored for their traditional appeal, accessibility, and consumer familiarity as the most common cannabis consumption method.
North America dominated the global legal marijuana market in 2024, capturing 69% of total revenue due to developed regulatory systems, advanced cultivation and distribution networks, and broad acceptance of both medical and adult-use cannabis across multiple jurisdictions.
The Asia Pacific market is poised for rapid expansion, with a 37.6% CAGR by 2034 due to evolving government policies, increased healthcare spending, and rising demand for plant-derived therapies across the region's developing markets.
A few global key players in the legal marijuana market include ABcann Medicinals, Inc.; Aphria Inc.; Aurora Cannabis; Canopy Growth Corporation; Cronos Group; GW Pharmaceuticals, Plc.; Lexaria Corporation; Maricann Inc.; Organigram Holdings Inc.; and Tilray.
Polaris Market Research has segmented the legal marijuana market report on the basis of product type, application, medical application, compound, mode of delivery, and region:
By Product Type Outlook (Revenue, USD Billion, 2020–2034)
Buds
Oils & Concentrates
Tinctures
By Application Outlook (Revenue, USD Billion, 2020–2034)
Medical
Industrial Hemp
Recreational
By Medical Application Outlook (Revenue, USD Billion, 2020–2034)
Chronic Pain
Arthritis
Migraine
Cancer
Other Medical Applications
By Compound Outlook (Revenue, USD Billion, 2020–2034)
Tetrahydrocannabinol (THC)-Dominant
Cannabidiol (CBD)-Dominant
Balanced THC & CBD
By Mode of Delivery Outlook (Revenue, USD Billion, 2020–2034)
Capsules
Concentrates
Edibles
Other Delivery Methods
By Regional Outlook (Revenue, USD Billion, 2020–2034)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Legal marijuana can be defined as cannabis and its derivatives that are cultivated, processed, and distributed in compliance with established laws for medical, therapeutic, and recreational purposes. The market is witnessing growth due to the rapid integration of cannabis into mainstream healthcare and wellness industries, driven by increasing scientific validation of its therapeutic benefits. This rapid growth has led to the development of standardized, high-quality products designed to meet diverse consumer needs, while boosting greater trust among both medical professionals and end-users. The demand is further boosted by ongoing innovation in product formulations and delivery methods as awareness of these benefits grows.
The rising level of institutional investments and corporate participation contributes to the expansion opportunities, as businesses recognize the important economic potential of the legal marijuana industry. Major players are leveraging advanced cultivation technologies, sophisticated branding strategies, and sustainable practices to differentiate themselves in a competitive market. This professionalization of the industry is improving product quality and availability and also contributing to its long-term legitimacy and stability, paving the way for sustained global growth.
Legal Marijuana Market Report Highlights
In terms of application, the recreational segment is projected to register a CAGR of 40.0% during the forecast period, driven by expanding adult-use legalization and evolving societal acceptance of recreational cannabis.
Based on product type, in 2024, the buds segment held a 64.1% market share, favored for their traditional appeal, accessibility, and consumer familiarity as the most common cannabis consumption method.
North America dominated the global legal marijuana market in 2024, capturing 69% of total revenue due to developed regulatory systems, advanced cultivation and distribution networks, and broad acceptance of both medical and adult-use cannabis across multiple jurisdictions.
The Asia Pacific market is poised for rapid expansion, with a 37.6% CAGR by 2034 due to evolving government policies, increased healthcare spending, and rising demand for plant-derived therapies across the region's developing markets.
A few global key players in the legal marijuana market include ABcann Medicinals, Inc.; Aphria Inc.; Aurora Cannabis; Canopy Growth Corporation; Cronos Group; GW Pharmaceuticals, Plc.; Lexaria Corporation; Maricann Inc.; Organigram Holdings Inc.; and Tilray.
Polaris Market Research has segmented the legal marijuana market report on the basis of product type, application, medical application, compound, mode of delivery, and region:
By Product Type Outlook (Revenue, USD Billion, 2020–2034)
Buds
Oils & Concentrates
Tinctures
By Application Outlook (Revenue, USD Billion, 2020–2034)
Medical
Industrial Hemp
Recreational
By Medical Application Outlook (Revenue, USD Billion, 2020–2034)
Chronic Pain
Arthritis
Migraine
Cancer
Other Medical Applications
By Compound Outlook (Revenue, USD Billion, 2020–2034)
Tetrahydrocannabinol (THC)-Dominant
Cannabidiol (CBD)-Dominant
Balanced THC & CBD
By Mode of Delivery Outlook (Revenue, USD Billion, 2020–2034)
Capsules
Concentrates
Edibles
Other Delivery Methods
By Regional Outlook (Revenue, USD Billion, 2020–2034)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
128 Pages
- Chapter 1. Introduction
- 1.1 Report Description
- 1.1.1 Objectives of the Study
- 1.1.2 Market Scope
- 1.1.3 Assumptions
- 1.2 Stakeholders
- Chapter 2. Executive Summary
- 2.1 Market Highlights
- Chapter 3. Research Methodology
- 3.1 Overview
- 3.1.1 Data Mining
- 3.2 Data Sources
- 3.2.1 Primary Sources
- 3.2.2 Secondary Sources
- Chapter 4. Legal Marijuana Market Insights
- 4.1 Legal Marijuana – Industry snapshot
- 4.2 Legal Marijuana Market Dynamics
- 4.2.1 Drivers and Opportunities
- 4.2.1.1 Favorable government initiatives in the U.S. and Europe
- 4.2.1.2 Growing prevalence of various chronic diseases
- 4.2.1.2.1 Cancer
- 4.2.1.2.2 Multiple sclerosis
- 4.2.1.3 Increase in tax revenues and eliminating the black-market economy
- 4.2.2 Restraints and Challenges
- 4.2.2.1 Low market penetration in developing and underdeveloped countries
- 4.3 Porter’s Five Forces Analysis
- 4.3.1 Bargaining Power of Suppliers (Moderate)
- 4.3.2 Threats of New Entrants: (Moderate)
- 4.3.3 Bargaining Power of Buyers (Low)
- 4.3.4 Threat of Substitute (Low)
- 4.3.5 Rivalry among existing firms (High)
- 4.4 SWOT Analysis, By Factor (political & legal, economic and technological)
- Chapter 5. Legal Marijuana Market Assessment by Product Type
- 5.1 Introduction
- 5.2 Buds
- 5.3 Oils & Concentrates
- 5.4 Tinctures
- Chapter 6. Legal Marijuana Market Assessment, by Application
- 6.1 Introduction
- 6.2 Medical
- 6.3 Industrial Hemp
- 6.4 Recreational
- Chapter 7. Legal Marijuana Market Assessment by Medical Application
- 7.1 Introduction
- 7.2 Chronic Pain
- 7.3 Arthritis
- 7.4 Migraine
- 7.5 Cancer
- 7.6 Other Medical Applications
- Chapter 8. Legal Marijuana Market Assessment by Compound
- 8.1 Introduction
- 8.2 Tetrahydrocannabinol (THC)-Dominant
- 8.3 Cannabidiol (CBD)-Dominant
- 8.4 Balanced THC & CBD
- Chapter 9. Legal Marijuana Market Assessment by Mode Of Delivery
- 9.1 Introduction
- 9.2 Capsules
- 9.3 Concentrates
- 9.4 Edibles
- 9.5 Other Delivery Methods
- Chapter 10. Legal Marijuana Market Assessment by Geography
- 10.1 Introduction
- 10.2 Legal Marijuana Market – North America
- 10.2.1 Legal Marijuana Market – U.S.
- 10.2.2 Legal Marijuana Market – Canada
- 10.2.3 Legal Marijuana Market – Mexico
- 10.3 Legal Marijuana Market – Europe
- 10.3.1 Legal Marijuana Market – Germany
- 10.3.2 Legal Marijuana Market – Croatia
- 10.3.3 Legal Marijuana Market – Finland
- 10.3.4 Legal Marijuana Market – Netherlands
- 10.3.5 Legal Marijuana Market – Romania
- 10.3.6 Legal Marijuana Market – Czech Republic
- 10.3.7 Legal Marijuana Market – Switzerland
- 10.4 Legal Marijuana Market – Asia Pacific
- 10.4.1 Legal Marijuana Market – Australia
- 10.5 Legal Marijuana Market – Middle East & Africa
- 10.5.1 Legal Marijuana Market – Israel
- 10.6 Legal Marijuana Market – Latin America
- 10.6.1 Legal Marijuana Market – Brazil
- 10.6.2 Legal Marijuana Market – Argentina
- 10.6.3 Legal Marijuana Market – Colombia
- Chapter 11. Competitive Landscape
- 11.1 Product Launch & Collaborations Both Are The Best Adopted Strategies by the Companies
- 11.2 Product Launch
- 11.3 Partnerships/Collaborations/Agreements/Exhibitions
- Chapter 12. The Company Profiles
- 12.1 Canopy Growth Corporation
- 12.1.1 Business Overview
- 12.1.2 Financial Snapshot
- 12.1.3 Products and Services
- 12.1.4 Recent Developments
- 12.2 Aphria Inc.
- 12.2.1 Business Overview
- 12.2.2 Financial Snapshot
- 12.2.3 Products and Services
- 12.2.4 Recent Developments
- 12.3 Aurora Cannabis
- 12.3.1 Business Overview
- 12.3.2 Financial Snapshot
- 12.3.3 Products and Services
- 12.3.4 Recent Developments
- 12.4 Maricann Inc.
- 12.4.1 Business Overview
- 12.4.2 Financial Snapshot
- 12.4.3 Products and Services
- 12.4.4 Recent Developments
- 12.5 Tilray
- 12.5.1 Business Overview
- 12.5.2 Financial Snapshot
- 12.5.3 Products and Services
- 12.5.4 Recent Developments
- 12.6 Cronos Group
- 12.6.1 Business Overview
- 12.6.2 Financial Snapshot
- 12.6.3 Products and Services
- 12.6.4 Recent Developments
- 12.7 Organigram Holdings Inc.
- 12.7.1 Business Overview
- 12.7.2 Financial Snapshot
- 12.7.3 Products and Services
- 12.7.4 Recent Developments
- 12.8 ABcann Medicinals, Inc.
- 12.8.1 Business Overview
- 12.8.2 Financial Snapshot
- 12.8.3 Products and Services
- 12.8.4 Recent Developments
- 12.9 GW Pharmaceuticals, Plc.
- 12.9.1 Business Overview
- 12.9.2 Financial Snapshot
- 12.9.3 Products and Services
- 12.10 Lexaria Corporation
- 12.10.1 Business Overview
- 12.10.2 Financial Snapshot
- 12.10.3 Products and Services
- 12.10.4 Recent Developments
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.